Clinical Trial Update: Autologous Gene Therapy for Artemis-Deficient SCID [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for autologous Artemis-deficient SCID gene therapy, currently recruiting in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Immunodeficiency

Drugs mentioned

• Autologous Artemis-deficient SCID gene therapy

Snippet

Sponsor: University of California, San Francisco | Conditions: Severe Combined Immunodeficiency | Phase 1, Phase 2 | Status: RECRUITING